CLINICAL_TRIALS
trial_result
· 2024-02-23
Clinical Trial Update: Outcomes of MIST for BPH: A Single-Institution Prospective Study [Phase 3]
Summary
A Phase 3 clinical trial update from a single institution evaluating MIST for benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Manitoba | Conditions: Benign Prostatic Hyperplasia | Phase 3 | Status: UNKNOWN